Bioprocess Technology Market Report 2026

Bioprocess Technology Market Overview

• Bioprocess Technology market size has reached to $28.71 billion in 2025 • Expected to grow to $59.03 billion in 2030 at a compound annual growth rate (CAGR) of 15.5% • Growth Driver: Bioprocess Technology Market Thrives As Chronic Diseases Prevail To Develop Advanced Therapies • Market Trend: Molecular Devices Unveils Custom Organoid Line Expansion Service Revolutionizing Drug Discovery Research In The Bioprocess Technology Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bioprocess Technology Market?

Bioprocessing technology is the process of producing biological products such as medicines, chemicals, and biofuels using living organisms such as bacteria, yeast, and cells. Bioprocess technology is used in the production of pharmaceuticals, meals, flavors, fuels, and chemicals with the of a biocatalyst such as an enzyme, microbe, plant cell, or animal cell in a bioreactor. The main types of bioprocess technologies are cell culture, cell expansion, flow cytometry, cell line development, and virus infiltration. Cell culture refers to the growth and maintenance of cells in a controlled environment, usually in vitro, under sterile and optimal conditions that often use bioprocessing technology to produce biologics in large quantities for research, clinical trials, and commercial use. They have a variety of applications in biopharmaceuticals, specialty products, industrial chemicals, and environment management aids and are also used by various end users such as hospitals, research labs, medical institutions, and others.

What Is The Bioprocess Technology Market Growth Forecast?

The bioprocess technology market size is expected to see rapid growth in the next few years. It will grow to $59.03 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing investments in biologics and biosimilars, rising adoption of continuous bioprocessing, expansion of personalized medicine production, growing focus on sustainable biomanufacturing, increasing integration of digital process control systems. Major trends in the forecast period include increasing adoption of single-use bioprocessing systems, rising demand for scalable cell culture technologies, growing integration of automation in bioreactors, expansion of advanced cell line development techniques, enhanced focus on process optimization and yield efficiency.

Global Bioprocess Technology Market Segmentation

1) By Type: Cell Culture, Cell Expansion, Flow Cytometry, Cell Line Development, Virus Filtration 2) By Application: Biopharmaceuticals, Specialty Products, Industry Chemicals, Environment Management Aid 3) By End User: Hospitals, Research labs, Medical Institutions, Other End Users Subsegments: 1) By Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture 2) By Cell Expansion: Adherent Cell Expansion, Suspension Cell Expansion 3) By Flow Cytometry: Cell Analysis, Cell Sorting 4) By Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development 5) By Virus Filtration: Viral Vector Production, Virus Filtration Techniques

What Is The Driver Of The Bioprocess Technology Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the bioprocess technology market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Bioprocess technology in the development and production of gene therapies, vaccines, cell culture and fermentation and monoclonal antibody production for chronic diseases to advance in the field of medicine and improving the quality of life for individuals. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition would increase by 99.5%, that is 142.66 million, by 2050. Therefore, the increasing prevalence of chronic diseases drives the growth of the bioprocess technology industry.

Key Players In The Global Bioprocess Technology Market

Major companies operating in the bioprocess technology market are Sartorius AG; Thermo Fisher Scientific Inc.; Lonza Group AG; F. Hoffmann-La Roche Ltd.; Becton Dickinson and Company; Merck KGa; GE Healthcare; Eppendorf AG; Bio-Rad Laboratories; Catalent Inc.; Advanced Instruments LLC; MilliporeSigma; Repligen Corporation; Danaher Corporation; PerkinElmer Inc.; Applikon Biotechnology; New Brunswick Scientific Co. Inc.; Avid Bioservices; Meissner Filtration Products; 3M; Eppendorf Biochip Systems; Fermenter Bioreactor; Solaris Biotechnology Srl; Aber Instruments; Cytiva

Global Bioprocess Technology Market Trends and Insights

Major companies operating in the bioprocess technology market are innovating services options, such as the custom organoid line expansion service, to gain a competitive edge in the market. The custom organoid line expansion service is a service that uses proprietary bioreactor and bioprocess technology to scale up the production of organoids. For instance, in July 2023, Molecular Devices LLC, a US-based Research and development company launched custom organoid line expansion service. The custom organoid line expansion service helps researchers to screen thousands to tens of thousands of drug candidates in parallel on organoids from the same source. It is designed to support next-generation drug discovery research and enables the development of more efficient, reproducible, and scalable patient-derived organoids (PDOs).

What Are Latest Mergers And Acquisitions In The Bioprocess Technology Market?

In September 2023, Repligen Corporation, a US-based company devoted to the development and production of materials used in the manufacture of biological drugs, acquired Metenova Corporation for an undisclosed amount. With this acquisition, Repligen Corporation aims to expand its product offerings and strengthen its position in the bioprocess market. Metenova is a Sewden-based innovator and manufacturer of bottom-mounted magnetic mixers for pharmaceutical and biotechnology use.

Regional Insights

North America was the largest region in the bioprocess technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioprocess technology market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Bioprocess Technology Market?

The bioprocess technology market consists of revenues earned by entities by providing biologics safety testing, and tangential flow filtration. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprocess technology market also includes sales of instruments, consumables, and accessories that include bioprocess analyzers, osmometers, incubators, and bioreactors used in bioprocessing technology services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioprocess Technology Market Report 2026?

The bioprocess technology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess technology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.